Journal profile · Radiology, Nuclear Medicine & Medical Imaging
Brachytherapy
ISSN 1538-4721 · eISSN 1873-1449 · Elsevier Inc. · UNITED STATES · Quarterly · Founded 2002
Brachytherapy: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.54; hybrid open access; APC about USD 3,000; median 115 days to acceptance (108 articles, last 24 months); community-reported acceptance: easy (Elsevier website: 61%); 264 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Brachytherapy is published by Elsevier Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Radiotherapy Techniques, Prostate Cancer Diagnosis and Treatment and Endometrial and Cervical Cancer Treatments, together about 48.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
An International Multidisciplinary Journal Official Journal of the American Brachytherapy SocietyBrachytherapy is an international and multidisciplinary journal that publishes original peer-reviewed articles and selected reviews on the techniques and clinical applications of interstitial and intracavitary radiation in the management of cancers. Laboratory and experimental research relevant to clinical practice is also included. Related disciplines include medical physics, medical oncology, and radiation oncology and radiology. Brachytherapy publishes technical advances, original articles, reviews, and point/counterpoint on controversial issues. Original articles that address any aspect of brachytherapy are invited. Letters to the Editor-in-Chief are encouraged.
From the journal's Aims & Scope
Research area (LetPub): Radiology, Nuclear Medicine & Medical Imaging
Editor-in-chief Michael ZelefskyPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 56, Canada 13, Germany 7, Spain 6, France 3 (102 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Radiotherapy TechniquesPhysics and Astronomy20.9%
- Prostate Cancer Diagnosis and TreatmentMedicine16.3%
- Endometrial and Cervical Cancer TreatmentsMedicine11.5%
- Prostate Cancer Treatment and ResearchMedicine8.7%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology5.5%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance3.9%
- Management of metastatic bone diseaseMedicine2.4%
- Radiation Therapy and DosimetryMedicine2.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.54LetPub ·
- Impact factor (publisher)
- 1.7Publisher website ·
- CiteScore 2026-06
- 2.8LetPub ·
- CiteScore (publisher)
- 2.8Publisher website ·
- SJR 2026-06
- 0.57LetPub ·
- SNIP 2026-06
- 0.76LetPub ·
- h-index
- 44LetPub ·
- h-index
- 66OpenAlex ·
- i10-index
- 1,082OpenAlex ·
- 2-year mean citedness
- 0.56OpenAlex ·
- Self-citation rate
- 23.5%LetPub ·
- Share of gold OA articles
- 10.49%LetPub ·
Volume
- Articles per year
- 101LetPub ·
Articles by year OpenAlex count · 6,689 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 99 | 18 | 5 |
| 2025 | 264 | 46 | 132 |
| 2024 | 371 | 62 | 275 |
| 2023 | 338 | 33 | 505 |
| 2022 | 292 | 40 | 685 |
| 2021 | 432 | 41 | 1,098 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
115 daysMedian, submission to acceptance · P25–P75 58 days – 155 days
- Acceptance to online
- median 50 days (103 articles)
- Submission to online
- median 162 days
- Sample
- 108 articles with submission and acceptance dates (255 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- 61%LetPub ·
- Acceptance rate (publisher)
- 50%Publisher website ·
- Submission to acceptance
- 124 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,000 / EUR 2,810 / GBP 2,400 / JPY 372,090 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 4,000 words
- Suggested reviewers
- Required
Article types accepted11, with length limits
- case reportBrachytherapy publishes Original Articles, Technical Notes, Reviews, and Point/Counterpoints on controversial issues. Case reports are considered if the informa…Length not stated
- case reportsIn general, case reports are discouraged; however, they may be considered if the information within the manuscript is of clinical importance and significance.Length not stated
- debates and controversies in brachytherapyThese articles are written by invitation of the editors and they focus on controversial topics that allow the authors to take opposing "sides" on the issue.Length not stated
- letters to the editorBrachytherapy publishes Original Articles, Technical Notes, Reviews, and Point/Counterpoints on controversial issues. Case reports are considered if the informa…Length not stated
- original articleBrachytherapy publishes Original Articles, Technical Notes, Reviews, and Point/Counterpoints on controversial issues. Case reports are considered if the informa…main text ≤ 250 words · abstract ≤ 250 words
- original articlesBrachytherapy will consider original articles describing aspects of brachytherapy clinical trials and translational research (i.e., those articles that unite cl…Length not stated
- reviewBrachytherapy publishes Original Articles, Technical Notes, Reviews, and Point/Counterpoints on controversial issues. Case reports are considered if the informa…Length not stated
- review articleThese articles should be critical, in-depth literature-based reviews that include the author's perspective. The reviews should not merely be catalogs of the lit…Length not stated
- review articlesThese articles should be critical, in-depth literature-based reviews that include the author's perspective.Length not stated
- technical noteBrachytherapy publishes Original Articles, Technical Notes, Reviews, and Point/Counterpoints on controversial issues. Case reports are considered if the informa…main text ≤ 2,500 words · abstract ≤ 250 words
- technical notesTechnical notes should be in the form of a brief communication highlighting the details of a brachytherapy technique, which effectively address a clinical issue…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Preprints
- AI use Declaration of generative AI in scientific writing
Generative AI use must be declared upon submission; AI tools may only be applied with human oversight and control, and authors remain responsible for the contents of their work. Model summary
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, …
Source ↗Publisher website ·- Conflicts of interest Disclosures and Acknowledgments
For ALL types of manuscript submissions, all listed authors must complete the ICMJE Form for Disclosure of Potential Conflicts of Interest, which has been integrated in to the submission process. A Disclosure/Conflict of Interest section should be placed after the text and before the References. It must include a disclosure/conflict of interest statement that refers to all the authors. Please eith…
Source ↗Publisher website ·- License & copyright Copyright
Copyright: authors complete a Journal Publishing Agreement upon acceptance; gold open access articles use a License Agreement. Model summary
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Open access publishing is available; details on the Open Access page. Model summary
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 2002
- ISSN
- 1538-4721
- Electronic ISSN
- 1873-1449
- Society / sponsor
- American Brachytherapy Society
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Brachytherapy
What CAS zone is Brachytherapy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Brachytherapy is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology / Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Brachytherapy?
The latest impact factor listed by LetPub is 1.54; CiteScore 2.8, h-index 66.
How long does peer review take at Brachytherapy?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 58–155 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy (Elsevier website: 61%)”; the journal's website gives an acceptance rate of 50%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Brachytherapy?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 4,000 words; Suggested reviewers: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Brachytherapy based?
Of the 102 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (56), Canada (13) and Germany (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Brachytherapy?
According to LetPub and DOAJ records, Brachytherapy is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Brachytherapy open access, and what is the APC?
Brachytherapy is a hybrid journal. For open-access publication: APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .